Batch BeaconUK recalls and safety alerts

Medicines recallMHRA

Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules recalled over a strength or dose problem

Wrong strength or doseMedium riskClass 3

Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

Check your product

Only products that match these details are covered. Have your pack in front of you.

17 identifiers listed for this notice.

  • Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules 7

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • 1211145
    • 1203816
    • 1211146
    • 1211147
    • 1207940
    • 1211148
    • 1203818
    Product licenceThe PL number on the carton.
    • PL 49718/0010
    • PL 49718/0011
    • PL 49718/0012
    • PL 49718/0013
    ExpiryOn the carton, blister or label.
    • 09/2025
    • 03/2025
    • 06/2025
    First distributedOn the product, its label or its packaging.
    • 23/02/2023
    • 07/07/2022
    • 24/10/2022

What to do now

Some batches of Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules may not contain the right amount of active ingredient.

  1. Keep taking your medicine unless a healthcare professional tells you otherwise.
  2. Check the batch number and expiry date on your pack against the list on this page.
  3. If it matches, your pharmacist can swap it or arrange an alternative.
  4. Report suspected side effects to the MHRA Yellow Card scheme.

Why it matters. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself.

Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(24)A/19). Quoted as issued.

Summary

Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

The risk

MDR number MDR 078-05/24 Company name

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules been recalled?

Some batches of Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules may not contain the right amount of active ingredient. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

How do I know if my medicine is affected?

Compare the batch code, product licence, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.

Do I need a new prescription?

If your pack is affected, your pharmacy can usually exchange it for an unaffected batch or another suitable product. Prescription medicines are replaced through your pharmacy or prescriber; you do not need to buy a new supply yourself. Many recalls are made at pharmacy or wholesaler level and do not require patients to act. The notice says which level applies.

Related notices